Clinical Trial Update: Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis [Phase 1]

View source ↗

Summary

Circassia Limited reports Phase 1 proteomics analysis identifying potential biomarkers for their peptide immunotherapy approach to cat allergy; the study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cat Allergy

Drugs mentioned

• Cat-PAD

Snippet

Sponsor: Circassia Limited | Conditions: Cat Allergy | Phase 1 | Status: COMPLETED